CancerVista
ctDNA liquid-biopsy in-house IVD for MRD detection, recurrence surveillance and therapy monitoring across solid tumors.
- Developer
- LIQOMICS
- Intended use
- Mrd
- Cancer scope
- Not reported
- Specimen
- Peripheral whole blood
- Molecular modality
- DNA mutation
- Current version
- CancerVista current in-house IVD
- Evidence context
- 0 structured studies · 0 indexed performance results · 1 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.